Key terms
About SRRK
Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the business of discovering, developing, and delivering innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest SRRK news
Mar 27
4:27pm ET
Scholar Rock initiated with a Strong Buy at Raymond James
Mar 26
7:06am ET
Piper Sandler Remains a Buy on Scholar Rock Holding (SRRK)
Mar 19
8:45pm ET
Buy Rating Affirmed for Scholar Rock on Strong SMA Pipeline and Strategic Developments
Mar 19
10:45am ET
Buy Rating Affirmed for Scholar Rock Holding on Strong Drug Pipeline Potential and Expansion into Obesity Market
Feb 24
8:34pm ET
Short Report: Bears boost WW exposure ahead of earnings after marketing debacle
Feb 15
9:13am ET
Scholar Rock Appoints New Director, Expands Board
Feb 06
8:22am ET
Scholar Rock data show potential benefit of SRK-439 for ‘healthy’ weight control
Jan 23
8:07am ET
FDA clears Scholar Rock’s IND application for apitegromab study for obesity
No recent news articles are available for SRRK
No recent press releases are available for SRRK
SRRK Financials
Key terms
Ad Feedback
SRRK Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
SRRK Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range